Sign Up Today and Learn More About Woolsey Pharmaceuticals Stock
Invest in or calculate the value of your shares in Woolsey Pharmaceuticals or other pre-IPO companies through EquityZen's platform.
Woolsey Pharmaceuticals Stock
Woolsey Pharmaceuticals specializes in reinventing ways to treat some of the world’s most challenging diseases.
About Woolsey Pharmaceuticals Stock
Founded
2019
Headquarters
New York, NY, US
Industries
Science and Engineering, Health Care, Biotechnology
Woolsey Pharmaceuticals Press Mentions
Stay in the know about the latest news on Woolsey Pharmaceuticals
Method for reducing caregiver burden associated with alzheimer's disease
patents • Apr 02, 2025
Method of treating patients with notch3 mutations
patents • Apr 02, 2025
Methods of treating traumatic encephalopathy syndrome
patents • Apr 02, 2025
Oral formulations of fasudil with ion exchange resin
patents • Apr 02, 2025
Woolsey Pharmaceuticals Completes B Round Extension To Advance Its ALS Program
prnewswire • Feb 28, 2025
Woolsey Pharmaceuticals Management
Leadership team at Woolsey Pharmaceuticals
Independent Director
David Epstein
Co-Founding Partner & Chief Executive Officer
Sven M. Jacobson
Join now and verify your accreditation status to gain access to:
- Woolsey Pharmaceuticals Current Valuation
- Woolsey Pharmaceuticals Stock Price
- Woolsey Pharmaceuticals Management
- Available deals in Woolsey Pharmaceuticals and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Woolsey Pharmaceuticals Cap Table and Funding History by Share Class and Liquidity Preferences
- Woolsey Pharmaceuticals Revenue and Financials
- Woolsey Pharmaceuticals Highlights
- Woolsey Pharmaceuticals Business Model
- Woolsey Pharmaceuticals Risk Factors
- Woolsey Pharmaceuticals Research Report from SACRA Research
Trading Woolsey Pharmaceuticals Stock
How to invest in Woolsey Pharmaceuticals stock?
Accredited investors can buy pre-IPO stock in companies like Woolsey Pharmaceuticals through EquityZen funds. These investments are made available by existing Woolsey Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Woolsey Pharmaceuticals stock?
Shareholders can sell their Woolsey Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."